Research Use Only - Important Disclaimer
All products listed on this website are intended for laboratory research use only and are not for human consumption, medical, veterinary, or household use. These products should only be handled by qualified professionals. We do not provide any dosage information, and the products must not be used as food additives, drugs, cosmetics, or for any other inappropriate applications. By purchasing, you acknowledge and agree to these terms.
Reta - GLP-3
Investigational Multi-Agonist Peptide
Reta GLP-3 is a triple agonist targeting GLP-1, GIP, and glucagon receptors, being explored for its powerful metabolic effects, especially in obesity and type 2 diabetes.
Usage:
Used in clinical trials and investigational studies for significant body fat reduction, appetite control, and glucose management.
Mechanism of Action:
Acts on GLP-1, GIP, and glucagon receptors to enhance insulin sensitivity, reduce appetite, and increase energy expenditure.
Benefits:
- Substantial weight loss
- Improved glycemic control
- Enhanced metabolic rate
Side Effects:
- Nausea
- Gastrointestinal discomfort
- Possible increased heart rate
Suggested Dosage:
Not specified
Half-life: Approximately 5–7 days
Delivery: Subcutaneous injection (weekly)